Thus, the nanoparticle-encapsulated curcumin treatment decreased the DM-induced increase in the Cx43 levels in the DRG and inhibited ATP signaling mediated by the P2Y12 receptor in DM rats. The gene discussed is GJA1; the disease is diabetes mellitus.